Background:
The T-cell surface glycoprotein CD4 is also known as the T-cell surface antigen T4/Leu-3. CD4 contains 3 Ig -like C2-type (immunoglobulin-like) domains and 1 Ig -like V-type (immunoglobulin-like) domain. CD4 is an accessory protein for MHC class II antigen/T-cell receptor interactions. CD4 induces lipid raft aggregation . CD4 is the primary receptor used by HIV-1 to enter host T cells. HIV infection causes a gradual decrease in the number of T cells with CD4 receptors. Therefore, healthcare professionals refer to the CD4 count to decide when to start treatment for HIV-infected patients.
Overview:
Antigen name: Human B7-2 / CD86 Protein, Fc Tag; Other names: CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; Sequence source: Human B7-2, Fc tag, high quality (CD6-H5257) expressed by human 293 cells (HEK293), with Fc tag; Molecular weight: The calculated molecular weight of the protein is 51.5 kDa . Due to glycosylation, the protein migrates at 66-100 kDa under reducing conditions and 120-140 kDa under non-reducing conditions (SDS-PAGE).
Packaging specifications:
Rhinogen ^® recombinant human B7-2 / CD86 protein (Fc tag) packaging specifications are as follows:

Characteristics:
Purity: Purity >95% in SDS-PAGE under reducing and non-reducing conditions.
Storage temperature:
This product can be stored for 12 months in a freeze-dried state at -20°C to -70°C; after reconstitution, it can be stored for 3 months at -70°C under sterile conditions. Please avoid repeated freezing and thawing.